India Patent Cases
2,823 decisions indexed
Page 48 of 95 · 2,823 total
Trex India Pvt. Ltd. v.Cde Asia Limited
The dispute originated from a suit for permanent injunction filed by Cde Asia Limited against Trex India Pvt. Ltd. regarding alleged infringement of its Patent No. 3072491 and Design No. 2626292 concerning the product 'FM 120 CONEXUS'. The present appeal challenged the Single Judge's order, but the High Court dismissed the appeal on a preliminary objection regarding its maintainability under the Commercial Courts Act.
S. N. Biri Factory Private Limited v.Mukesh Chand Khandelwal & Anr.
The Delhi High Court addressed a dispute concerning artistic works used in matchstick branding, where the Petitioner alleged that Respondent No. 1's new copyright was deceptively similar to their existing registered designs and trademarks. Despite the Deputy Registrar of Copyrights initially rejecting the objection, the Court found prima facie evidence suggesting imitation of unique features and misappropriation of phrases like 'शहे नशाह मािचस NO. 99'. Consequently, the High Court granted a stay on the effect of the impugned copyright registration while the matter proceeds.
Cellresearch Corporation Pte Ltd v.Controller Of Patents And Designs
The appeal challenges an order rejecting Cellresearch Corporation's divisional patent application (No. 10875/DELNP/2013) based on lack of distinct invention from its parent application (No. 1492/DELNP/2007). The appellant argues that the rejection is invalid because the objections raised in the parent application had already been complied with.
Janssen Pharmaceuticals Inc And Others v.Clevus Lifesciences and others
The plaintiffs, exclusive licensees of the patent holder for Indian Patent No. 232231, filed a suit alleging infringement by defendant No. 1 and others who were manufacturing and offering Canagliflozin tablets under brand names like Adkana. The court found a prima facie case in favor of the plaintiffs.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against generic drug manufacturers, including Vee Excel Drugs, alleging infringement of Indian Patent No. IN 243301 related to Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the patent was vulnerable to revocation due to prior claiming and noted attempts at evergreening by the patentees. Consequently, the plaintiffs failed to establish a prima facie case, leading to the dismissal of all interim injunction applications.
Boehringer Ingelheim Pharma Gmbh & Co. v.Vee Excel Drugs And Pharmaceuticals Private Ltd.
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies, seeking permanent injunctions against infringing Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the prima facie case and found that the patent was vulnerable to revocation due to prior claiming and attempts at evergreening by the plaintiffs. Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin as the active pharmaceutical ingredient.
Intex Technologies (India) Ltd v.Telefonaktiebolaget L M Ericsson (Pub)
This Delhi High Court judgment addressed cross-appeals concerning the validity and infringement of Standard Essential Patents (SEPs) related to telecom technology. The court affirmed that Ericsson's patents were prima facie essential and infringed, finding Intex to be an unwilling licensee. Despite arguments regarding SEPs being unknown in Indian law, the court upheld the necessity of FRAND compliance to ensure parity with global implementers.
Ifp Energies Nouvelles v.The Assistant Controller of Patents and Designs, Government of India
Ifp Energies Nouvelles appealed the rejection of its patent application (No. 1373/CHE/2015) by the Controller of Patents and Designs, Chennai. The appellant argued that the rejection order was non-speaking and failed to consider their submissions or prior acceptance in the USA. The High Court agreed, finding that the material contentions were ignored.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Alkem Laboratories Ltd & Anr., Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma against various Indian pharmaceutical companies seeking permanent injunctions for infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court found that the plaintiffs failed to establish a prima facie case for granting interim relief. Furthermore, the court expressed concern regarding the patent's vulnerability due to prior claiming and alleged attempts at 'evergreening.' Consequently, all applications for injunction were dismissed, allowing defendants to continue manufacturing and selling products containing Linagliptin.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
Boehringer Ingelheim Pharma sought permanent injunctions against various Indian pharmaceutical companies, alleging infringement of Patent No. IN 243301 related to Linagliptin tablets. The Delhi High Court examined the applications for interim injunction across multiple connected suits. The court found that the plaintiffs failed to establish a prima facie case, noting concerns about potential patent vulnerability due to prior claiming and attempts at evergreening. Consequently, all interim injunction applications were dismissed, allowing defendants to continue manufacturing and selling the products.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Mankind Pharma Limited
Boehringer Ingelheim Pharma filed multiple suits seeking permanent injunction against Indian pharmaceutical companies for allegedly infringing Patent No. IN 243301, which covers Linagliptin compounds. The Delhi High Court examined the applications for interim injunction across all connected matters. The court found that the suit patent was vulnerable to revocation due to prior claiming and noted attempts by the plaintiffs towards 'evergreening.' Consequently, the court dismissed all applications for interim injunction, allowing defendants to manufacture and sell products containing Linagliptin.
Telefonaktiebolaget Lm Ericsson (Pub) v.Intex Technologies (India) Limited
This Delhi High Court judgment addressed a complex dispute involving Standard Essential Patents (SEPs) between Ericsson and Intex. The court examined whether the patents were essential, if Intex was infringing them, and if Intex had acted as an unwilling licensee despite Ericsson's FRAND commitments. Ultimately, the court found that the patents were prima facie valid and infringed, compelling Intex to pay the full royalty amount.
Boehringer Ingelheim Pharma Gmbh And Co. Kg & Anr. v.Vee Excel Drugs and Pharmaceuticals Private Ltd. & Ors., Alkem Laboratories Ltd & Anr., Micro Labs Limited, Natco Pharma Limited & Anr., Mankind Pharma Limited
This judgment addresses multiple suits filed by Boehringer Ingelheim Pharma seeking permanent injunction against various Indian pharmaceutical companies for infringing Patent No. IN 243301, which covers Linagliptin compounds. The court examined the applications for interim injunction and found that the plaintiffs failed to establish a prima facie case. Furthermore, the judge expressed concerns regarding the patent's vulnerability due to prior claiming and alleged attempts at evergreening by the patentees. Consequently, all interim injunction applications were dismissed, allowing the defendants to continue manufacturing and selling products containing Linagliptin.
Diamond Star Global Sdn. Bhd. v.Joint Controller Of Patents And Designs
The appellant sought a patent for 'Hygiene Wash,' a skin care preparation using wood vinegar derived from the Rhizophora apiculata tree. The Controller rejected the application, but the High Court found that the invention possessed an inventive step by identifying guaiacol-free wood vinegar and determining the optimal concentration (18-22%) to selectively target harmful bacteria while preserving beneficial lactic acid bacteria.
Yang, Liping v.Controller Of Patents And Designs
Yang, Liping appealed an order dated November 18, 2013, which refused his Indian Patent Application (No. 2769/DELNEP/2004). The refusal was based on the patent not meeting Section 2(1)(j) of the Indian Patent Act, 1970. The court issued directions for service and filing of replies to proceed with the appeal.
Hatsun Agro Product Ltd. v.M/S.Himachal Milk Food Products
Hatsun Agro Product Ltd. filed a civil suit against M/S.Himachal Milk Food Products alleging infringement of its trademarks and copyrights, specifically concerning the use of similar containers and labels on dairy products like Ghee. The plaintiff sought permanent injunctions and damages for passing off. However, before the court could rule on the merits of the case, the plaintiff moved to withdraw the suit, which was subsequently granted by the Madras High Court.
Microsoft Corporation v.The Assistant Controller Of Patents And Designs
Microsoft Corporation appealed the Assistant Controller's order rejecting its patent application (No. 487/DELNP/2006). The rejection was based on vague grounds, including failure to adhere to a non-defined 'method step format' and falling under Section 3(k) as an algorithm-based invention. The High Court found the Controller's reasoning lacking focus and unsustainable.
Boehringer Ingelheim Pharma Gmbh And Co Kg v.The Controller Of Patents & Anr.
Boehringer Ingelheim Pharma challenged the rejection of its application seeking to quash a pre-grant opposition filed against its patent application. The petitioner argued that the opposition lacked reasonable justification, while the court addressed the issue of abuse of process under Section 25(1).
Ischemix Llc v.The Controller Of Patents
Ischemix Llc appealed the Controller's rejection of its patent application (No. 4380/DELNP/2013) concerning pharmaceutical products for treating ischemia. The appellant argued that the rejection, based on prior art D-5/D-6 and Section 3(d), was flawed because these documents were not cited during the initial hearing. The High Court quashed the impugned order and remanded the application for de novo consideration.
Kent Ro Systems Pvt Ltd v.Pushpendra Yadav
Kent Ro Systems Pvt Ltd filed a suit alleging design and trademark infringement against Pushpendra Yadav and others, specifically targeting water purifiers sold on Flipkart. The plaintiff asserted that the defendants' products infringed their registered Design No. 219309 for a water purifier and used deceptively similar marks like AQUA GRAND+ infringing KENT GRAND+. The Delhi High Court allowed the interim application, finding prima facie evidence of both design piracy and trademark infringement.
Emitech Gesellschaft Fur Emissionstechnologie MBH v.Controller General Of Patents Designs And Trademarks And Anr
Emitech Gesellschaft Fur Emissionstechnologie MBH filed an appeal challenging the rejection of its Indian Patent Application No. 9107/DELNP/2011 by the Controller General of Patents Designs and Trademarks. The patent application relates to a heatable honeycomb body designed for motor vehicles, allowing exhaust gas flow through electrically conductive layers. Emitech contended that the rejection was erroneous as the invention introduced novel features not found in existing prior art.
Alternative Gene Expression S L v.The Controller Of Patents
The appellant challenged the Patent Office's order rejecting its patent application, which held that the method of producing recombinant proteins by destruction of pupa was non-patentable under Section 3(b). The High Court found the rejection order to be cryptic and lacking reasoned justification despite detailed submissions from the appellant.
M/S SUMOTEK INNOVATION PVT. LTD. AND ANR. v.Assam Power Distribution Co. Ltd.
The petitioner filed a writ appeal claiming that the respondent, APDCL, was infringing its patent rights related to a Prepaid/Postpaid Electricity Supply Machine. The court dismissed the appeal, holding that since the remedy for patent infringement is compensation or injunction under the Patents Act, 1970, the matter must be heard by a Civil Court of competent jurisdiction.
Vifor International Ltd. v.Aishwarya Health Care Private Limited
Vifor International Ltd., a global pharmaceutical company, filed suit against Aishwarya Health Care Private Limited alleging infringement of its patented drug, Ferric Carboxymaltose. The plaintiffs claimed that the defendants intended to launch a generic version, 'Ferocose FCM', which would infringe upon their patent (No. 221536). After considering the prima facie case and balance of convenience, the Delhi High Court granted an ad-interim injunction.
Cambridge Enterprises Ltd. v.The Controller General Of Patents And Designs And Anr
The appellant challenged an order from the Deputy Controller of Patents & Designs that refused Patent No. 2216/KOLNP/2009, claiming it was filed beyond the statutory time limit. The court examined the filing records and found that the application was correctly filed on June 5, 2009, within the stipulated deadline.
Blackberry Limited v.Assistant Controller Of Patents And Designs
Blackberry Limited appealed the refusal of its patent application concerning a method for text selection on touch screens. The core issue before the Delhi High Court was not the technical merits of the invention itself, but rather the procedural flaw in the Assistant Controller's rejection order. The court found that the impugned order lacked discernible reasoning and appeared to be a mechanical replication of claims, rendering the decision arbitrary. Consequently, the High Court quashed the refusal order and remanded the matter back to the Patent Office for a fresh, reasoned consideration.
Ecomax Solutions Pvt. Ltd. v.Energeo Building Solutions Llp & Ors.
The dispute concerned alleged patent infringement regarding Ecomax Solutions' Automatic Tube Cleaning System (ATCS) against Energeo Building Solutions' AFCS. The court examined whether the defendants' system infringed the claims of IN 382118. The court found that the AFCS was prima facie dissimilar to the suit patent, leading to the dismissal of the plaintiff's injunction application.
Aska Equipments Private Limited v.Ramanlal Kishandas Kothari & Ors.
The appellant, Aska Equipments Private Limited, sought to withdraw its appeal and related applications. The counsel requested liberty to file an application seeking revocation of a patent in the Trial Court, which could then be transferred to the High Court under Section 104 of the Patents Act, 1970.
Medtronic Xomed, Inc v.Controller General Of Patents, Designs and Trademarks And Anr
The Calcutta High Court addressed an opposition matter (OA/4/2018/PT/KOL) involving Medtronic Xomed, Inc. The court noted that no counsel appeared for the appellant on the hearing date. Consequently, the matter was adjourned to March 30, 2023, with specific directions issued to the respondent authorities to serve a copy of the application on the appellant and file an Affidavit of Service.
Satbir Singh v.Assistant Controller Of Patents
Satbir Singh appealed the rejection of his patent application for a 'Pellet Feed Manufacturing Plant'. The Assistant Controller rejected the application citing lack of inventive steps and that it was merely an arrangement or re-arrangement. The High Court set aside the impugned order, finding that the objection under Section 3(f) was not afforded to the Appellant during the examination process.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.